$8.65 billion EBITDA for full year 2024,sees a rise of 14% year-on-year (YoY) Full year 2024 dividend of $3.41 billion confirmed,growing by 5% per annum
SUZHOU,China,Feb. 6,2025-- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody
Personetics\' latest product release empowers financial institutions to develop highly personalized customer experiences that democratize financial advice,inspire action,and drive business value
SHENZHEN,China,Feb. 6,2025-- Elegoo,a rapidly developing brand in global smart manufacturing,announces today on its website that pre-ordersfor the highly anticipated Centauri Carbon,the company\'sfir
Cobots,via low ASPs and safety coupled with AI value-adds,will unlock new commercial applications for robotics
SHANGHAI,Feb. 6,2025--ShanghaiHenlius Biotech,Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy\'s Laboratories SA,wholly-owned subsidiary of Dr. Reddy\'s Laborator